BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Myriad Genetics, Inc. 

320 Wakara Way

Salt Lake City  Utah  84108  U.S.A.
Phone: 801-584-3600 Fax: 801-584-3640


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Myriad Genetics, Inc. (MYGN) Launches #ProstateAnswers Social Media Campaign To Help Educate The Public About Prostate Cancer And Genetic Testing 1/26/2015 12:47:43 PM
Myriad Genetics, Inc. (MYGN) And Pathway Diagnostics Agree To Settle BRCA Patent Infringement Case 1/26/2015 10:46:24 AM
Invitae Announces Settlement In Lawsuit With Myriad Genetics, Inc. (MYGN) 1/26/2015 8:41:58 AM
Myriad Genetics, Inc. (MYGN) Names Johnathan M. Lancaster As Vice President Of Medical Affairs 1/22/2015 7:51:07 AM
Myriad Genetics, Inc. (MYGN) To Announce 2Q15 Financial Results On February 3, 2015 1/22/2015 7:45:32 AM
Myriad Genetics, Inc. (MYGN) Wins CE Mark for Tumor BRACAnalysis CDx™ 1/8/2015 6:31:19 AM
Myriad Genetics, Inc. (MYGN) Names Bernard Tobin As President Of Crescendo Bioscience 12/22/2014 7:44:13 AM
Myriad Genetics, Inc. (MYGN) Snags FDA Approval of BRACAnalysis CDx as Companion Diagnostic for Lynparza 12/22/2014 6:28:23 AM
Myriad Genetics, Inc. (MYGN) Receives FDA Approval Of BRACAnalysis CDx™ As Companion Diagnostic For Lynparza™ (olaparib) In Ovarian Cancer Patients 12/19/2014 11:12:26 AM
Ambry Genetics Defeats Appeal By Myriad Genetics, Inc. (MYGN) To Restrict Market For Breast-Ovarian Cancer Genetic Testing 12/18/2014 10:33:17 AM
12345678910...